drugset / Trial / NCT03906617
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Timeline
- Start
- 2019-04-10
- Primary completion
- 2022-04-10
- Completion
- 2022-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 24 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 42 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 266 mg | Other |
| Subject | Dexamethasone | Small molecule | 8 mg | Other |
| Subject | Epinephrine | Other / unclassified | — | Other |
Indications
No indication recorded.